share_log

FDA Concluded New Regulatory Pathway For CBD Is Needed That Balances Individuals' Desire For Access To CBD Products; FDA Convened High-Level Internal Working Group To Explore Potential Regulatory Pathways For CBD Products

FDA Concluded New Regulatory Pathway For CBD Is Needed That Balances Individuals' Desire For Access To CBD Products; FDA Convened High-Level Internal Working Group To Explore Potential Regulatory Pathways For CBD Products

美国食品和药物管理局得出结论,需要新的CBD监管途径来平衡个人获得CBD产品的愿望;FDA召集了高级别内部工作组,探讨CBD产品的潜在监管途径
Benzinga Real-time News ·  2023/01/26 11:09

FDA Concluded New Regulatory Pathway For CBD Is Needed That Balances Individuals' Desire For Access To CBD Products; FDA Convened High-Level Internal Working Group To Explore Potential Regulatory Pathways For CBD Products

美国食品和药物管理局得出结论,需要新的CBD监管途径来平衡个人获得CBD产品的愿望;FDA召集了高级别内部工作组,探讨CBD产品的潜在监管途径

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发